Liminatus Announces Pricing of $4.0 Million Public Offering
17 Feb 2026 //
GLOBENEWSWIRE
Liminatus Pharma Inks $30M Equity Deal With Capital Trust Group
30 Oct 2025 //
GLOBENEWSWIRE
Liminatus to Launch Subsidiary for $500M BNB Crypto Investment
28 Jul 2025 //
GLOBENEWSWIRE
Liminatus Eyes $500M Digital Asset Investment Plan
25 Jul 2025 //
GLOBENEWSWIRE
Liminatus Pharma Advances Digital Asset-Linked Capital Strategy
24 Jul 2025 //
GLOBENEWSWIRE
Liminatus Pharma Begins Review of Blockchain-Integrated Strategy
22 Jul 2025 //
GLOBENEWSWIRE
Program CD47, provided the CMC service by GenScript to InnobationBio will further be advanced
05 Dec 2022 //
PRNEWSWIRE

Market Place
Sourcing Support